Endometriosis Management Beyond Hormonal and Surgical Options- Focus on Physical Activity as Adjunct Therapy
DOI:
https://doi.org/10.12775/JEHS.2025.86.66744Keywords
endometriosis, inflammation, hormonal therapy, physiotherapy, physical activity, dysmenorrhea, pain managementAbstract
Introduction:
Endometriosis is a chronic, estrogen-dependent inflammatory disorder affecting millions of women worldwide, often causing debilitating pelvic pain, infertility, and significant reductions in quality of life. Although hormonal and surgical treatments remain the standard of care, many patients experience persistent symptoms or intolerable side effects, underscoring the need for complementary and alternative approaches.
Aim of the Study:
This review aims to synthesize current evidence on alternative treatments for endometriosis, with a particular focus on the potential roles of physical activity and physiotherapy, while highlighting critical gaps in the existing research.
Materials and Methods
The review covers publications published in 2003-2025. The search for publications in the Pubmed electronic database was carried out using the following keywords: endometriosis, inflammation, physical activity, pelvic floor muscles, inflammaging, physiotherapy, pathogenesis, cytokines.
Conclusions : Preliminary studies suggest that regular physical activity and targeted physiotherapy interventions may alleviate pain, reduce inflammation, and improve psychological well-being in women with endometriosis. However, current evidence is limited by small sample sizes, inconsistent methodologies, and short follow-up periods. There is an urgent need for well-designed, large-scale research focusing specifically on women with endometriosis to evaluate alternative treatment strategies. Future studies should systematically assess the types, intensities, and durations of physical activity that are most effective, and rigorously investigate the benefits and risks of hormonal therapies. Without robust data, clinicians cannot offer clear, evidence-based recommendations, making further research essential to improve outcomes and quality of life for women affected by this complex condition.
References
1. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014 May;10(5):261–75.
2. Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022 Nov 14;379:e070750.
3. Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol. 2017 Feb 1;209:3–7.
4. Koninckx PR, Ussia A, Adamyan L, Tahlak M, Keckstein J, Wattiez A, et al. The epidemiology of endometriosis is poorly known as the pathophysiology and diagnosis are unclear. Best Pract Res Clin Obstet Gynaecol. 2021 Mar;71:14–26.
5. Leone Roberti Maggiore U, Chiappa V, Ceccaroni M, Roviglione G, Savelli L, Ferrero S, et al. Epidemiology of infertility in women with endometriosis. Best Pract Res Clin Obstet Gynaecol. 2024 Feb 1;92:102454.
6. Sarria-Santamera A, Orazumbekova B, Terzic M, Issanov A, Chaowen C, Asúnsolo-del-Barco A. Systematic Review and Meta-Analysis of Incidence and Prevalence of Endometriosis. Healthcare. 2020 Dec 30;9(1):29.
7. Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D’Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009 Jul;92(1):68–74.
8. Kristjansdottir A, Rafnsson V, Geirsson RT. Comprehensive evaluation of the incidence and prevalence of surgically diagnosed pelvic endometriosis in a complete population. Acta Obstet Gynecol Scand. 2023 Mar 25;102(10):1329–37.
9. Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020 Mar 26;382(13):1244–56.
10. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014 May;10(5):261–75.
11. Sachedina A, Todd N. Dysmenorrhea, Endometriosis and Chronic Pelvic Pain in Adolescents. J Clin Res Pediatr Endocrinol. 2020 Feb 6;12(Suppl 1):7–17.
12. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019 Nov;15(11):666–82.
13. Quality of life in women with endometriosis: a systematic review and meta-analysis.
14. Bonavina G, Taylor HS. Endometriosis-associated infertility: From pathophysiology to tailored treatment. Front Endocrinol. 2022;13:1020827.
15. Hu PW, Zhang XL, Yan XT, Qi C, Jiang GJ. Association between depression and endometriosis using data from NHANES 2005-2006. Sci Rep. 2023 Oct 31;13(1):18708.
16. Seli E, Berkkanoglu M, Arici A. Pathogenesis of endometriosis. Obstet Gynecol Clin North Am. 2003 Mar 1;30(1):41–61.
17. Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage. Front Immunol. 2013;4:9.
18. Jeung I, Cheon K, Kim MR. Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis. BioMed Res Int. 2016;2016:2916070.
19. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril. 2001 Jan;75(1):1–10.
20. Hapangama DK, Kamal AM, Bulmer JN. Estrogen receptor β: the guardian of the endometrium. Hum Reprod Update. 2015 Mar 1;21(2):174–93.
21. Viganò P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004 Apr 1;18(2):177–200.
22. Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S. Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci. 2002 Mar;955:75–85; discussion 86-88, 396–406.
23. Monnin N, Fattet AJ, Koscinski I. Endometriosis: Update of Pathophysiology, (Epi) Genetic and Environmental Involvement. Biomedicines. 2023 Mar 22;11(3):978.
24. Zanatta A, Pereira RMA, da Rocha AM, Cogliati B, Baracat EC, Taylor HS, et al. The Relationship Among HOXA10, Estrogen Receptor α, Progesterone Receptor, and Progesterone Receptor B Proteins in Rectosigmoid Endometriosis: A Tissue Microarray Study. Reprod Sci. 2015 Jan 1;22(1):31–7.
25. Bruner-Tran KL, Ding T, Osteen KG. Dioxin and Endometrial Progesterone Resistance. Semin Reprod Med. 2010 Jan;28(01):059–68.
26. Viganò P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004 Apr 1;18(2):177–200.
27. Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009.
28. Brown J, Crawford TJ, Allen C, Hopewell S, Prentice A. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2017 Jan 23;1(1):CD004753.
29. Allen C, Hopewell S, Prentice A. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004753.
30. Caruso S, Cianci S, Caruso G, Iraci Sareri M, Gulino FA, Palumbo M. Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis‑associated chronic pelvic pain. Eur J Obstet Gynecol Reprod Biol. 2025 Jan 1;304:10–5.
31. Viviano M, Benagiano G, Guo SW, Pluchino N. Why do oestrogens matter: systematic review and meta-analysis assessing GnRH antagonists, considering add-back therapy, for endometriosis-associated pain. Reprod Biomed Online. 2024 Oct;49(4):104321.
32. Verma A, Konje JC. Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients. Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):112–5.
33. Vercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:68–91.
34. Bandini V, Giola F, Ambruoso D, Cipriani S, Chiaffarino F, Vercellini P. The natural evolution of untreated deep endometriosis and the effect of hormonal suppression: A systematic literature review and meta-analysis. Acta Obstet Gynecol Scand. 2024;103(9):1722–35.
35. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet Lond Engl. 2021 Feb 27;397(10276):839–52.
36. Hee L, Kettner LO, Vejtorp M. Continuous use of oral contraceptives: an overview of effects and side-effects. Acta Obstet Gynecol Scand. 2013 Feb;92(2):125–36.
37. Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Crosignani PG. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol. 2008 Apr;22(2):275–306.
38. Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014 Mar 10;2014(3):CD009590.
39. Dunselman G a. J, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod Oxf Engl. 2014 Mar;29(3):400–12.
40. Guerriero S, Saba L, Pascual MA, Ajossa S, Rodriguez I, Mais V, et al. Transvaginal ultrasound vs magnetic resonance imaging for diagnosing deep infiltrating endometriosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2018 May;51(5):586–95.
41. Guerriero S, Alcázar JL, Pascual MA, Ajossa S, Perniciano M, Piras A, et al. Deep Infiltrating Endometriosis: Comparison Between 2-Dimensional Ultrasonography (US), 3-Dimensional US, and Magnetic Resonance Imaging. J Ultrasound Med Off J Am Inst Ultrasound Med. 2018 Jun;37(6):1511–21.
42. Chapron C, Santulli P, de Ziegler D, Noel JC, Anaf V, Streuli I, et al. Ovarian endometrioma: severe pelvic pain is associated with deeply infiltrating endometriosis. Hum Reprod Oxf Engl. 2012 Mar;27(3):702–11.
43. Schippert C, Witte Y, Bartels J, Garcia-Rocha GJ, Jentschke M, Hillemanns P, et al. Reproductive capacity and recurrence of disease after surgery for moderate and severe endometriosis – a retrospective single center analysis. BMC Womens Health. 2020 Jul 13;20:144.
44. Porpora MG, Pallante D, Ferro A, Crisafi B, Bellati F, Benedetti Panici P. Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study. Fertil Steril. 2010 Feb;93(3):716–21.
45. Working group of ESGE E and WES, Keckstein J, Becker CM, Canis M, Feki A, Grimbizis GF, et al. Recommendations for the surgical treatment of endometriosis. Part 2: deep endometriosis. Hum Reprod Open. 2020 Jan 1;2020(1):hoaa002.
46. Booth, F.W., Roberts, C.K. and Laye, M.J. (2012), Lack of Exercise Is a Major Cause of Chronic Diseases. Comprehensive Physiology, 2: 1143-1211.
47. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006 Dec 14;444(7121):860–7.
48. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017 Jan 3;127(1):1–4.
49. Das UN. Metabolic syndrome X: an inflammatory condition? Curr Hypertens Rep. 2004 Feb;6(1):66–73.
50. Nesci A, Carnuccio C, Ruggieri V, D’Alessandro A, Di Giorgio A, Santoro L, et al. Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship. Int J Mol Sci. 2023 May 22;24(10):9087.
51. Thornton P, Reader V, Digby Z, Smolak P, Lindsay N, Harrison D, et al. Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796. J Pharmacol Exp Ther. 2024 Feb 15;388(3):813–26.
52. Liew PX, Kubes P. The Neutrophil’s Role During Health and Disease. Physiol Rev. 2019 Apr 1;99(2):1223–48.
53. Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018 Oct;14(10):576–90.
54. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9.
55. Nimmo MA, Leggate M, Viana JL, King JA. The effect of physical activity on mediators of inflammation. Diabetes Obes Metab. 2013 Sep 1;15(s3):51–60.
56. Del Forno S, Cocchi L, Arena A, Pellizzone V, Lenzi J, Raffone A, et al. Effects of Pelvic Floor Muscle Physiotherapy on Urinary, Bowel, and Sexual Functions in Women with Deep Infiltrating Endometriosis: A Randomized Controlled Trial. Med Kaunas Lith. 2023 Dec 29;60(1):67.
57. Hill DA, Taylor CA. Dyspareunia in Women. Am Fam Physician. 2021 May 15;103(10):597–604.
58. Starzec-Proserpio M, Frawley H, Bø K, Morin M. Effectiveness of nonpharmacological conservative therapies for chronic pelvic pain in women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025 Jan 1;232(1):42–71.
59. Yong PJ, Sadownik L, Brotto LA. Concurrent deep-superficial dyspareunia: prevalence, associations, and outcomes in a multidisciplinary vulvodynia program. J Sex Med. 2015 Jan;12(1):219–27.
60. Chen Y, Ullah A, Chen W, Xuan J, Huang X, Liang S, et al. Cytokine modulation in pelvic organ prolapse and urinary incontinence: from molecular insights to therapeutic targets. Mol Med. 2024 Nov 13;30:214.
61. Del Forno S, Cocchi L, Arena A, Pellizzone V, Lenzi J, Raffone A, et al. Effects of Pelvic Floor Muscle Physiotherapy on Urinary, Bowel, and Sexual Functions in Women with Deep Infiltrating Endometriosis: A Randomized Controlled Trial. Medicina (Mex). 2023 Dec 29;60(1):67.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Michalina Simachi, Michalina Janiszewska, Beata Imbirska , Natalia Ramlau, Dominika Kolenda, Zuzanna Fischer, Michał Hładki, Marta Prager-Zimny, Michalina Cyrulik, Marcin Podolak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 22
Number of citations: 0
